NCT01204099 2018-05-16Study of PX-866 and Docetaxel in Solid TumorsSeagen Inc.Phase 1/2 Completed223 enrolled
NCT01252628 2018-05-16Phase 1 and 2 Study of PX-866 and CetuximabSeagen Inc.Phase 1/2 Completed178 enrolled
NCT01616199 2018-05-16Study of PX-866 and Vemurafenib in Patients With Advanced MelanomaSeagen Inc.Phase 1/2 Terminated24 enrolled